-
1
-
-
0344827261
-
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
-
Agarwal C., Singh R.P., Dhanalakshmi S., Tyagi A.K., Tecklenburg M., Sclafani R.A., and Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22 (2003) 8271-8282
-
(2003)
Oncogene
, vol.22
, pp. 8271-8282
-
-
Agarwal, C.1
Singh, R.P.2
Dhanalakshmi, S.3
Tyagi, A.K.4
Tecklenburg, M.5
Sclafani, R.A.6
Agarwal, R.7
-
2
-
-
0034924760
-
Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1?
-
Akalin I., Güllü I.H., Kurdoglu M., and Marangoz S. Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1?. Med. Hypotheses 57 (2001) 221-223
-
(2001)
Med. Hypotheses
, vol.57
, pp. 221-223
-
-
Akalin, I.1
Güllü, I.H.2
Kurdoglu, M.3
Marangoz, S.4
-
3
-
-
0036800192
-
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
-
Baker A.H., Edwards D.R., and Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115 (2002) 3719-3727
-
(2002)
J. Cell Sci.
, vol.115
, pp. 3719-3727
-
-
Baker, A.H.1
Edwards, D.R.2
Murphy, G.3
-
4
-
-
0033601769
-
Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
-
Beliën A.T., Paganetti P.A., and Schwab M.E. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144 (1999) 373-384
-
(1999)
J. Cell Biol.
, vol.144
, pp. 373-384
-
-
Beliën, A.T.1
Paganetti, P.A.2
Schwab, M.E.3
-
5
-
-
0000391746
-
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
-
Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., and Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2 (2000) 737-744
-
(2000)
Nat. Cell Biol.
, vol.2
, pp. 737-744
-
-
Bergers, G.1
Brekken, R.2
McMahon, G.3
Vu, T.H.4
Itoh, T.5
Tamaki, K.6
Tanzawa, K.7
Thorpe, P.8
Itohara, S.9
Werb, Z.10
Hanahan, D.11
-
6
-
-
0035003785
-
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
-
Bergsten E., Uutela M., Li X., Pietras K., Östman A., Heldin C., Alitalo K., and Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat. Cell Biol. 3 (2001) 512-516
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 512-516
-
-
Bergsten, E.1
Uutela, M.2
Li, X.3
Pietras, K.4
Östman, A.5
Heldin, C.6
Alitalo, K.7
Eriksson, U.8
-
8
-
-
0035500490
-
The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis
-
Chang C., and Werb Z. The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis. Trends. Cell Biol. 11 (2001) S37-S43
-
(2001)
Trends. Cell Biol.
, vol.11
-
-
Chang, C.1
Werb, Z.2
-
9
-
-
0026592966
-
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G to T and A to C substitutions
-
Cheng K.C., Cahill D.S., Kasai H., Nishimura S., and Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G to T and A to C substitutions. J. Biol. Chem. 267 (1992) 166-172
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 166-172
-
-
Cheng, K.C.1
Cahill, D.S.2
Kasai, H.3
Nishimura, S.4
Loeb, L.A.5
-
10
-
-
0041352075
-
The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle
-
Curry Jr. T.E., and Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24 (2003) 428-465
-
(2003)
Endocr. Rev.
, vol.24
, pp. 428-465
-
-
Curry Jr., T.E.1
Osteen, K.G.2
-
11
-
-
34248583886
-
MAP kinase signalling pathways in cancer
-
Dhillon A.S., Hagan S., and Kolch W. MAP kinase signalling pathways in cancer. Oncogene 26 (2007) 3279-3290
-
(2007)
Oncogene
, vol.26
, pp. 3279-3290
-
-
Dhillon, A.S.1
Hagan, S.2
Kolch, W.3
-
12
-
-
18344390450
-
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling
-
Dunn K.L., Espino P.S., Drobic B., He S., and Davie J.R. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem. Cell Biol. 83 (2005) 1-14
-
(2005)
Biochem. Cell Biol.
, vol.83
, pp. 1-14
-
-
Dunn, K.L.1
Espino, P.S.2
Drobic, B.3
He, S.4
Davie, J.R.5
-
13
-
-
0036512208
-
New functions for the matrix metalloproteinases in cancer progression
-
Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-173
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 161-173
-
-
Egeblad, M.1
Werb, Z.2
-
14
-
-
0036466854
-
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma
-
Giannelli G., Bergamini C., Marinosci F., Fransvea E., Quaranta M., Lupo L., Schiraldi O., and Antonaci S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int. J. Oncol. 97 (2002) 425-431
-
(2002)
Int. J. Oncol.
, vol.97
, pp. 425-431
-
-
Giannelli, G.1
Bergamini, C.2
Marinosci, F.3
Fransvea, E.4
Quaranta, M.5
Lupo, L.6
Schiraldi, O.7
Antonaci, S.8
-
15
-
-
29244473831
-
RNA interference against Hec1 inhibits tumor growth in vivo
-
Gurzov E.N., and Izquierdo M. RNA interference against Hec1 inhibits tumor growth in vivo. Gene Ther. 13 (2006) 1-7
-
(2006)
Gene Ther.
, vol.13
, pp. 1-7
-
-
Gurzov, E.N.1
Izquierdo, M.2
-
16
-
-
33745161394
-
MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells
-
Honma N., Genda T., Matsuda Y., Yamagiwa S., Takamura M., Ichida T., and Aoyagi Y. MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells. Lab. Invest. 86 (2006) 687-696
-
(2006)
Lab. Invest.
, vol.86
, pp. 687-696
-
-
Honma, N.1
Genda, T.2
Matsuda, Y.3
Yamagiwa, S.4
Takamura, M.5
Ichida, T.6
Aoyagi, Y.7
-
18
-
-
2542473135
-
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis
-
Huynh H., Nguyen T.T., Chow K.P., Tan P.H., Soo K.C., and Tran E. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol. 3 (2003) 1-21
-
(2003)
BMC Gastroenterol.
, vol.3
, pp. 1-21
-
-
Huynh, H.1
Nguyen, T.T.2
Chow, K.P.3
Tan, P.H.4
Soo, K.C.5
Tran, E.6
-
19
-
-
33846781365
-
Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma
-
Huynh H., Soo K.C., Chow P.K., and Tran E. Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Mol. Cancer Ther. 6 (2007) 138-146
-
(2007)
Mol. Cancer Ther.
, vol.6
, pp. 138-146
-
-
Huynh, H.1
Soo, K.C.2
Chow, P.K.3
Tran, E.4
-
20
-
-
0027458323
-
Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
-
Ikeda K., Saitoh S., Tsubota A., Arase Y., Chayama K., Kumada H., Watanabe G., and Tsurumaru M. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71 (1993) 19-25
-
(1993)
Cancer
, vol.71
, pp. 19-25
-
-
Ikeda, K.1
Saitoh, S.2
Tsubota, A.3
Arase, Y.4
Chayama, K.5
Kumada, H.6
Watanabe, G.7
Tsurumaru, M.8
-
21
-
-
0036793871
-
Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma
-
Ikeguchi M., Ueta T., Yamane Y., Hirooka Y., and Kaibara N. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin. Cancer Res. 8 (2002) 3131-3136
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 3131-3136
-
-
Ikeguchi, M.1
Ueta, T.2
Yamane, Y.3
Hirooka, Y.4
Kaibara, N.5
-
22
-
-
17344372847
-
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma
-
Ito Y., Sasaki Y., Horimoto M., Wada S., Tanaka Y., Kasahara A., Ueki T., Hirano T., Yamamoto H., Fujimoto J., Okamoto E., Hayashi N., and Hori M. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27 (2003) 951-958
-
(2003)
Hepatology
, vol.27
, pp. 951-958
-
-
Ito, Y.1
Sasaki, Y.2
Horimoto, M.3
Wada, S.4
Tanaka, Y.5
Kasahara, A.6
Ueki, T.7
Hirano, T.8
Yamamoto, H.9
Fujimoto, J.10
Okamoto, E.11
Hayashi, N.12
Hori, M.13
-
23
-
-
0037109597
-
Milk thistle for the treatment of liver disease. A systematic review and meta-analysis
-
Jacobs B.P., Dennehy C., Ramirez G., Sapp J., and Lawrence V.A. Milk thistle for the treatment of liver disease. A systematic review and meta-analysis. Am. J. Med. 113 (2002) 506-515
-
(2002)
Am. J. Med.
, vol.113
, pp. 506-515
-
-
Jacobs, B.P.1
Dennehy, C.2
Ramirez, G.3
Sapp, J.4
Lawrence, V.A.5
-
24
-
-
0030903321
-
Protective effects of silymarin against photocarcinogenesis in a mouse skin model
-
Katiyar S.K., Korman N.J., Mukhtar H., and Agarwal R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst. 89 (1997) 556-566
-
(1997)
J. Natl. Cancer Inst.
, vol.89
, pp. 556-566
-
-
Katiyar, S.K.1
Korman, N.J.2
Mukhtar, H.3
Agarwal, R.4
-
25
-
-
0031031148
-
Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression
-
Kim Y.M., DeVera M.E., Watkins S.C., and Billiar T.R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272 (1997) 1402-1411
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 1402-1411
-
-
Kim, Y.M.1
DeVera, M.E.2
Watkins, S.C.3
Billiar, T.R.4
-
26
-
-
35248859158
-
Effects and mechanisms of silibinin on human hepatoma cell lines
-
Lah J.J., Cui W., and Hu K. Effects and mechanisms of silibinin on human hepatoma cell lines. World J. Gastroenterol. 13 (2007) 5299-5305
-
(2007)
World J. Gastroenterol.
, vol.13
, pp. 5299-5305
-
-
Lah, J.J.1
Cui, W.2
Hu, K.3
-
27
-
-
0029807306
-
Differentiationial activation of mitogen-activated protein kinases by nitric-oxide-related species
-
Lander H.M., Jacovina A.T., Davis R.J., and Tauras J.M. Differentiationial activation of mitogen-activated protein kinases by nitric-oxide-related species. J. Biol. Chem. 271 (1996) 19705-19709
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 19705-19709
-
-
Lander, H.M.1
Jacovina, A.T.2
Davis, R.J.3
Tauras, J.M.4
-
29
-
-
0030452899
-
Mechanisms of liver disease
-
Losser M.R., and Payen D. Mechanisms of liver disease. Semin. Liver Dis. 16 (1996) 357-367
-
(1996)
Semin. Liver Dis.
, vol.16
, pp. 357-367
-
-
Losser, M.R.1
Payen, D.2
-
30
-
-
33947587168
-
Prognostic molecular markers in hepatocellular carcinoma: a systematic review
-
Mann C.D., Neal C.P., Garcea G., Manson M.M., Dennison A.R., and Berry D.P. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur. J. Cancer 43 (2007) 979-992
-
(2007)
Eur. J. Cancer
, vol.43
, pp. 979-992
-
-
Mann, C.D.1
Neal, C.P.2
Garcea, G.3
Manson, M.M.4
Dennison, A.R.5
Berry, D.P.6
-
31
-
-
0037183886
-
Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2
-
Martin-Lluesma S., Stucke V.M., and Nigg E.A. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297 (2002) 2267-2270
-
(2002)
Science
, vol.297
, pp. 2267-2270
-
-
Martin-Lluesma, S.1
Stucke, V.M.2
Nigg, E.A.3
-
32
-
-
0032774153
-
Inhibitory guanine nucleotide regulatory protein activation of mitogen activated protein kinase in hepatocellular carcinoma
-
McKillop I.H., Schmidt C.M., Cahill P.A., and Sitzmann J.V. Inhibitory guanine nucleotide regulatory protein activation of mitogen activated protein kinase in hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 11 (1999) 761-768
-
(1999)
Eur. J. Gastroenterol. Hepatol.
, vol.11
, pp. 761-768
-
-
McKillop, I.H.1
Schmidt, C.M.2
Cahill, P.A.3
Sitzmann, J.V.4
-
33
-
-
0035313981
-
The MEK1-ERK MAP kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells
-
Mitsui H., Takuwa N., Maruyama T., Maekawa H., Hirayama M., Sawatari T., Hashimoto N., Takuwa Y., and Kimura S. The MEK1-ERK MAP kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int. J. Cancer 92 (2001) 55-62
-
(2001)
Int. J. Cancer
, vol.92
, pp. 55-62
-
-
Mitsui, H.1
Takuwa, N.2
Maruyama, T.3
Maekawa, H.4
Hirayama, M.5
Sawatari, T.6
Hashimoto, N.7
Takuwa, Y.8
Kimura, S.9
-
34
-
-
2942672061
-
Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells
-
Mohan S., Dhanalakshmi S., Mallikarjuna G.U., Singh R.P., and Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 320 (2004) 183-189
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.320
, pp. 183-189
-
-
Mohan, S.1
Dhanalakshmi, S.2
Mallikarjuna, G.U.3
Singh, R.P.4
Agarwal, R.5
-
35
-
-
0028956461
-
Silybum marianum (Carduus marianus)
-
Morazzoni P., and Bombardelli E. Silybum marianum (Carduus marianus). Fitoterapia 66 (1995) 3-42
-
(1995)
Fitoterapia
, vol.66
, pp. 3-42
-
-
Morazzoni, P.1
Bombardelli, E.2
-
36
-
-
0001943908
-
Vascular changes and hemodynamics in hepatocellular carcinoma
-
Okuda K., and Peter R.L. (Eds), Wiley, New York, NY
-
Nakashima T. Vascular changes and hemodynamics in hepatocellular carcinoma. In: Okuda K., and Peter R.L. (Eds). Hepatocellular carcinoma (1976), Wiley, New York, NY 169-203
-
(1976)
Hepatocellular carcinoma
, pp. 169-203
-
-
Nakashima, T.1
-
37
-
-
15844391973
-
Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas
-
Nakatsukasa H., Ashida K., Higashi T., Ohguchi S., Tsuboi S., Hino N., Nouso K., Urabe Y., Kinugasa N., Yoshida K., Uematsu S., Ishizaki M., Kobayashi Y., and Tsuji T. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology 24 (1996) 82-88
-
(1996)
Hepatology
, vol.24
, pp. 82-88
-
-
Nakatsukasa, H.1
Ashida, K.2
Higashi, T.3
Ohguchi, S.4
Tsuboi, S.5
Hino, N.6
Nouso, K.7
Urabe, Y.8
Kinugasa, N.9
Yoshida, K.10
Uematsu, S.11
Ishizaki, M.12
Kobayashi, Y.13
Tsuji, T.14
-
38
-
-
23944435911
-
Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma
-
Osada S., Kanematsu M., Imai H., Goshima S., and Sugiyama Y. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma. J. Am. Coll. Surg. 201 (2005) 405-411
-
(2005)
J. Am. Coll. Surg.
, vol.201
, pp. 405-411
-
-
Osada, S.1
Kanematsu, M.2
Imai, H.3
Goshima, S.4
Sugiyama, Y.5
-
39
-
-
0028218474
-
Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis
-
Oshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994) 253-264
-
(1994)
Mutat. Res.
, vol.305
, pp. 253-264
-
-
Oshima, H.1
Bartsch, H.2
-
40
-
-
33746268320
-
Molecular pathways in hepatocellular carcinoma
-
Panga R., Tsea E., and Poon R.T. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 240 (2006) 157-169
-
(2006)
Cancer Lett.
, vol.240
, pp. 157-169
-
-
Panga, R.1
Tsea, E.2
Poon, R.T.3
-
42
-
-
0035840841
-
Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets
-
Pfeilschifter J., Eberhardt W., and Huwiler A. Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets. Eur. J. Pharmacol. 429 (2001) 279-286
-
(2001)
Eur. J. Pharmacol.
, vol.429
, pp. 279-286
-
-
Pfeilschifter, J.1
Eberhardt, W.2
Huwiler, A.3
-
43
-
-
7044270445
-
Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function
-
Poon R.T., and Fan S.T. Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl. 10 (2004) 813-815
-
(2004)
Liver Transpl.
, vol.10
, pp. 813-815
-
-
Poon, R.T.1
Fan, S.T.2
-
44
-
-
0034941503
-
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years
-
Poon R.T., Fan S.T., Lo C., Ng I.O., Liu C., Lam C., and Wong J. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann. Surg. 234 (2001) 63-70
-
(2001)
Ann. Surg.
, vol.234
, pp. 63-70
-
-
Poon, R.T.1
Fan, S.T.2
Lo, C.3
Ng, I.O.4
Liu, C.5
Lam, C.6
Wong, J.7
-
45
-
-
0034906314
-
Coexpression of Inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases
-
Rahman M.A., Dhar D.K., Yamaguchi E., Maruyama S., Sato T., Hayashi H., Ono T., Yamanoi A., Kohno H., and Nagasue N. Coexpression of Inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin. Cancer Res. 7 (2001) 1325-1332
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 1325-1332
-
-
Rahman, M.A.1
Dhar, D.K.2
Yamaguchi, E.3
Maruyama, S.4
Sato, T.5
Hayashi, H.6
Ono, T.7
Yamanoi, A.8
Kohno, H.9
Nagasue, N.10
-
47
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
Roberts P.J., and Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26 (2007) 3291-3310
-
(2007)
Oncogene
, vol.26
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
48
-
-
0025605014
-
Nitrite from inflammatory cells-a cancer risk factor in ulcerative colitis?
-
Roediger W.E., Laurson M.J., and Radcliffe B.C. Nitrite from inflammatory cells-a cancer risk factor in ulcerative colitis?. Dis. Colon Rectum 33 (1990) 1034-1036
-
(1990)
Dis. Colon Rectum
, vol.33
, pp. 1034-1036
-
-
Roediger, W.E.1
Laurson, M.J.2
Radcliffe, B.C.3
-
49
-
-
0035211762
-
The use of silymarin in the treatment of liver diseases
-
Saller R., Meier R., and Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 61 (2001) 2035-2063
-
(2001)
Drugs
, vol.61
, pp. 2035-2063
-
-
Saller, R.1
Meier, R.2
Brignoli, R.3
-
51
-
-
33749161559
-
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma
-
Schuierer M.M., Bataille F., Weiss T.S., Hellerbrand C., and Bosserhoff A.K. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol. Rep. 16 (2006) 451-456
-
(2006)
Oncol. Rep.
, vol.16
, pp. 451-456
-
-
Schuierer, M.M.1
Bataille, F.2
Weiss, T.S.3
Hellerbrand, C.4
Bosserhoff, A.K.5
-
52
-
-
29844437146
-
Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine
-
Shariftabrizi A., Nifli A., Ansari M., Saadat F., Ebrahimkhani M.R., Alizadeh N., Nasseh A., Alexaki V., Dehpour A.R., Castanas E., and Khorramizadeh M.R. Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine. Eur. J. Pharm. 530 (2006) 33-39
-
(2006)
Eur. J. Pharm.
, vol.530
, pp. 33-39
-
-
Shariftabrizi, A.1
Nifli, A.2
Ansari, M.3
Saadat, F.4
Ebrahimkhani, M.R.5
Alizadeh, N.6
Nasseh, A.7
Alexaki, V.8
Dehpour, A.R.9
Castanas, E.10
Khorramizadeh, M.R.11
-
54
-
-
0030877443
-
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 W, a novel inhibitor
-
Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A., and Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 W, a novel inhibitor. Cancer Res. 57 (1997) 3300-3304
-
(1997)
Cancer Res.
, vol.57
, pp. 3300-3304
-
-
Thomsen, L.L.1
Scott, J.M.2
Topley, P.3
Knowles, R.G.4
Keerie, A.5
Frend, A.J.6
-
55
-
-
16644390138
-
Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma
-
Tsuboi Y., Ichida T., Sugitani S., Genda T., Inayoshi J., Takamura M., Matsuda Y., Nomoto M., and Aoyagi Y. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Inter. 24 (2004) 432-436
-
(2004)
Liver Inter.
, vol.24
, pp. 432-436
-
-
Tsuboi, Y.1
Ichida, T.2
Sugitani, S.3
Genda, T.4
Inayoshi, J.5
Takamura, M.6
Matsuda, Y.7
Nomoto, M.8
Aoyagi, Y.9
-
56
-
-
0036847718
-
Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis
-
Tyagi A.K., Singh R.P., Agarwal C., Chan D.C., and Agarwal R. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis. Clin. Cancer Res. 8 (2002) 3512-3519
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 3512-3519
-
-
Tyagi, A.K.1
Singh, R.P.2
Agarwal, C.3
Chan, D.C.4
Agarwal, R.5
-
57
-
-
4544287556
-
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages
-
Tyagi A., Agarwal C., Harrison G., Glode L.M., and Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25 (2004) 1711-1720
-
(2004)
Carcinogenesis
, vol.25
, pp. 1711-1720
-
-
Tyagi, A.1
Agarwal, C.2
Harrison, G.3
Glode, L.M.4
Agarwal, R.5
-
58
-
-
28544439164
-
Silibinin efficacy against human hepatocellular carcinoma
-
Varghese L., Agarwal C., Tyagi A., Singh R.P., and Agarwal R. Silibinin efficacy against human hepatocellular carcinoma. Clin. Cancer Res. 11 (2005) 8441-8448
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 8441-8448
-
-
Varghese, L.1
Agarwal, C.2
Tyagi, A.3
Singh, R.P.4
Agarwal, R.5
-
59
-
-
33846100785
-
The Ndc80/HEC1 complex is a contact protein for kinetochore-microtubule attachment
-
Wei R.R., Al-Bassam J., and Harrison S.C. The Ndc80/HEC1 complex is a contact protein for kinetochore-microtubule attachment. Nat. Struct. Mol. Biol. 14 (2007) 54-59
-
(2007)
Nat. Struct. Mol. Biol.
, vol.14
, pp. 54-59
-
-
Wei, R.R.1
Al-Bassam, J.2
Harrison, S.C.3
-
60
-
-
0034859659
-
Silymarin: a review of its clinical properties in the management of hepatic disorders
-
Wellington K., and Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15 (2001) 465-489
-
(2001)
BioDrugs
, vol.15
, pp. 465-489
-
-
Wellington, K.1
Jarvis, B.2
-
61
-
-
0026522216
-
Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay
-
Weyhenmeyer R., Mascher H., and Birkmayer J. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int. J. Clin. Pharmacol. Ther. Toxicol. 30 (1992) 134-138
-
(1992)
Int. J. Clin. Pharmacol. Ther. Toxicol.
, vol.30
, pp. 134-138
-
-
Weyhenmeyer, R.1
Mascher, H.2
Birkmayer, J.3
-
62
-
-
1442335098
-
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma
-
Wiesenauer C.A., Yip-Schneider M.T., Wang Y., and Schmidt C.M. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J. Am. Coll. Surg. 198 (2004) 410-421
-
(2004)
J. Am. Coll. Surg.
, vol.198
, pp. 410-421
-
-
Wiesenauer, C.A.1
Yip-Schneider, M.T.2
Wang, Y.3
Schmidt, C.M.4
-
63
-
-
0030970553
-
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma
-
Yamamoto H., Itoh F., Adachi Y., Sakamoto H., Adachi M., Hinoda Y., and Imai K. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 112 (1997) 1290-1296
-
(1997)
Gastroenterology
, vol.112
, pp. 1290-1296
-
-
Yamamoto, H.1
Itoh, F.2
Adachi, Y.3
Sakamoto, H.4
Adachi, M.5
Hinoda, Y.6
Imai, K.7
-
64
-
-
0029741643
-
Recurrence of hepatocellular carcinoma after surgery
-
Yamamoto J., Kosuge T., and Takayama T. Recurrence of hepatocellular carcinoma after surgery. Br. J. Surg. 83 (1998) 1219-1222
-
(1998)
Br. J. Surg.
, vol.83
, pp. 1219-1222
-
-
Yamamoto, J.1
Kosuge, T.2
Takayama, T.3
-
65
-
-
0042736063
-
Anti-angiogenic effect of silymarin on colon cancer lovo cell line
-
Yang S., Lin J., Chen W., and Chiu J. Anti-angiogenic effect of silymarin on colon cancer lovo cell line. J. Surg. Res. 113 (2003) 133-138
-
(2003)
J. Surg. Res.
, vol.113
, pp. 133-138
-
-
Yang, S.1
Lin, J.2
Chen, W.3
Chiu, J.4
-
66
-
-
30944447568
-
The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions
-
Yoon S., and Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 (2006) 21-44
-
(2006)
Growth Factors
, vol.24
, pp. 21-44
-
-
Yoon, S.1
Seger, R.2
-
67
-
-
33749836283
-
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors
-
Yoshida T., Hisamoto T., Akiba J., Koga H., Nakamura K., Tokunaga Y., Hanada S., Kumemura H., Maeyama M., Harada M., Ogata H., Yano H., Kojiro M., Ueno T., Yoshimura A., and Sata M. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 25 (2006) 6056-6066
-
(2006)
Oncogene
, vol.25
, pp. 6056-6066
-
-
Yoshida, T.1
Hisamoto, T.2
Akiba, J.3
Koga, H.4
Nakamura, K.5
Tokunaga, Y.6
Hanada, S.7
Kumemura, H.8
Maeyama, M.9
Harada, M.10
Ogata, H.11
Yano, H.12
Kojiro, M.13
Ueno, T.14
Yoshimura, A.15
Sata, M.16
-
68
-
-
0032717556
-
Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention
-
Zhao J., and Agarwal R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 20 (1999) 2101-2108
-
(1999)
Carcinogenesis
, vol.20
, pp. 2101-2108
-
-
Zhao, J.1
Agarwal, R.2
|